These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 2747747

  • 21. Erythropoietin therapy in patients with chronic renal failure.
    Pinevich AJ, Petersen J.
    West J Med; 1992 Aug; 157(2):154-7. PubMed ID: 1441466
    [Abstract] [Full Text] [Related]

  • 22. Impact of erythropoietin on the dialysis prescription.
    Van Wyck DB.
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):71-5. PubMed ID: 1928083
    [Abstract] [Full Text] [Related]

  • 23. Treatment of anaemia of progressive renal failure with recombinant human erythropoietin. A preliminary report.
    Salim KA, Salim S, Mathew T.
    J Assoc Physicians India; 1992 Jan; 40(1):42-3. PubMed ID: 1634463
    [Abstract] [Full Text] [Related]

  • 24. r.hu-erythropoietin (EPO) treatment of pre-ESRD patients slows the rate of progression of renal decline.
    Tapolyai M, Kadomatsu S, Perera-Chong M.
    BMC Nephrol; 2003 Jun 17; 4():3. PubMed ID: 12809563
    [Abstract] [Full Text] [Related]

  • 25. The clinical effects of recombinant human erythropoietin for the treatment of anemia in end stage renal disease patients on dialysis.
    Uthayanaka Y, Jirajan B, Krairithichai U, Jantavanich N.
    Southeast Asian J Trop Med Public Health; 1993 Sep 17; 24(3):577-82. PubMed ID: 8160072
    [Abstract] [Full Text] [Related]

  • 26. Who should receive recombinant human erythropoietin?
    Van Stone JC.
    Semin Nephrol; 1989 Mar 17; 9(1 Suppl 2):3-7. PubMed ID: 2669084
    [Abstract] [Full Text] [Related]

  • 27. [Effect of the treatment with human recombinant erythropoietin on anemia in children with end-stage kidney failure. French multicenter study].
    Sinnassamy P, Andre JL, Treize G, Leroy B.
    Arch Fr Pediatr; 1993 Mar 17; 50(3):201-8. PubMed ID: 8338412
    [Abstract] [Full Text] [Related]

  • 28. Iron balance following recombinant human erythropoietin therapy for anemia associated with chronic renal failure.
    Hotta T, Ogawa H, Saito A, Ito A.
    Int J Hematol; 1991 Jun 17; 54(3):195-200. PubMed ID: 1747454
    [Abstract] [Full Text] [Related]

  • 29. Guidelines for recombinant human erythropoietin therapy.
    Eschbach JW, Adamson JW.
    Am J Kidney Dis; 1989 Aug 17; 14(2 Suppl 1):2-8. PubMed ID: 2667349
    [Abstract] [Full Text] [Related]

  • 30. [Treatment of anemia in patients on a regular dialysis program using human recombinant erythropoietin].
    Sulková S, Kvasnicka J, Kasl M, Kozlová J, Podrouzek P, Bartůnková J, Válek A.
    Cas Lek Cesk; 1989 Sep 29; 128(40):1257-60. PubMed ID: 2582471
    [Abstract] [Full Text] [Related]

  • 31. [Recombinant human erythropoietin in the therapy of anemia in hemodialyzed patients].
    Kakuk G, Kárpáti I, Mátyus J.
    Orv Hetil; 1990 Oct 28; 131(43):2365-6, 2369-71. PubMed ID: 2234936
    [Abstract] [Full Text] [Related]

  • 32. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results.
    Phair JP, Abels RI, McNeill MV, Sullivan DJ.
    Arch Intern Med; 1993 Dec 13; 153(23):2669-75. PubMed ID: 8250662
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Effect of erythropoietin treatment on tissue oxygenation in patients with severe transfusion dependent renal anaemia.
    Landgraf H, Grützmacher P, Garcia-Bartels C, Bergmann M, Ehrly AM, Schoeppe W.
    Eur J Med; 1993 Dec 13; 2(7):393-7. PubMed ID: 8258026
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Study of recombinant human erythropoietin treatment on the anemia of predialysis patients].
    Furukawa A, Numata A, Imagawa A, Kaifu Y, Sumikura T, Miyake H, Obayashi S, Nakazora H, Hirohata M, Miki S.
    Nihon Jinzo Gakkai Shi; 1992 Jun 13; 34(6):693-700. PubMed ID: 1479709
    [Abstract] [Full Text] [Related]

  • 37. Effectiveness of low-dose erythropoietin in predialysis chronic renal failure patients.
    Mitwalli A, Abuaisha H, al Wakeel J, al Mohaya S, Alam AA, el Gamal H, Fayed H.
    Nephrol Dial Transplant; 1993 Jun 13; 8(10):1085-8. PubMed ID: 8272220
    [Abstract] [Full Text] [Related]

  • 38. [Initial response to treatment with erythropoietin in anemia caused by chronic renal insufficiency].
    Sánchez Casajús A, Barrau J, Gómez Alamillo C, Jaurrieta F.
    Sangre (Barc); 1990 Feb 13; 35(1):82-4. PubMed ID: 2333585
    [Abstract] [Full Text] [Related]

  • 39. Monitoring considerations in recombinant human erythropoietin therapy.
    Ogden DA.
    Semin Nephrol; 1989 Mar 13; 9(1 Suppl 2):12-5. PubMed ID: 2669080
    [Abstract] [Full Text] [Related]

  • 40. [The effect of recombinant human erythropoietin on erythrocyte lines in patients with anemia and chronic renal insufficiency].
    Marisavljević D, Djukanović Lj, Lezajić V.
    Srp Arh Celok Lek; 1992 Mar 13; 120(9-10):281-5. PubMed ID: 1306020
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.